Fatty liver in overweight and obese patients in Western part of Saudi Arabia

Journal of the Bahrain Medical Society

Volumn 17, Issue 2, 2005, Pages 95-99

  Qari, Faiza A ^a,b   Al Ghamdi, Aisha ^c  

^a Medical Department   (Saudi Arabia)

^b KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^c NONE

Author keywords

And abdominal ultrasound; Fatty liver; NASH; Obesity; Overweight

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CHOLESTEROL; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; THYROTROPIN; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; HEPATOMEGALY; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; REVIEW; RISK FACTOR; SAUDI ARABIA; SEX RATIO; STATISTICAL ANALYSIS; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL;

EID: 22044451613     PISSN: 10156321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Ludwig J, Viggiano TR, McGill DB, et al. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Cli Proc 1980; 55:434-438.
2. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Is J Med 1979; 67: 811-816.3.
3. McCullough AJ. Update on non alcoholic fatty liver disease. J Clin Gasroenterol 2002; 34:255-262.
4. Jick SS, Stender M, Myers MW. Frequency of liver disease in type 2 diabetic patients treated with oral ant diabetic agents. Diabetes Care 1999; 22: 20672071.
5. Al-Quorain A, Satti MB, AL-Hamdan AR , AL-Gindan Y, Ibrahim E, Khatib R, AL-Freihi H. Pattern of chronic liver disease in the eastern province of Saudi Arabia. A hospital -based clinicopathological study. Trop Georg Med 1994; 46:358-360.
6. EL-Hassan AY, Ibrahim EM, AL-Mulhim FA, Nabhan AA, Chmmas MY. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical feature and influence on patient management. B J Rdiol 1992; 65:774-778.
7. Jorgensen M, Roberta N. Nonalcoholic fatty liver disease. Gastroenterology Nursing 2003; 26:150-154.
8. Powell EE, Cookesley EGE, Hanson R. The nature history of non alcoholic steatohepatitis: a follow -up study of forty-two patients for up to 21 years. Hepatology 1990; 11:74-80.
9. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84:1513-1517.
10. Falck-Ytter Y, Younossi ZM, Marchesini G et al Clinical features and nature history of non-alcoholic steatosis syndrome. Semin Liv Dis 2001; 21:17-26.
11. Joy, Diamond, Thava, Vallipuram R, Scott, and Brain B. Diagnosis of fatty liver disease: is biopsy necessary? Eur J of Gastroenterol Hepatol 2003; 15:539-543.
12. Joseph AEA, Dewlbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the "bright" liver) Br J Radiol 1979; 57: 23-27.
13. Luyckx FH, Lefebvre PJ, Scheen AJ, Non alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26:98-106.
14. Angulo P, Lindor KD Treatment of non alcoholic fatty liver: present and emerging therapies. Semin Liver Dis 2001; 21:81-88.
15. AL-Hazmi MA, Warsy AS. Prevalence of overweight and obesity in diabetic and non-diabetic Saudis. East Mediterr Health J 2000; 6: 276-282.
16. AL-Malki JS, AL-Jaser MH, Warsy AS. Overweight and obesity in Saudi females of childbearing age. Int J Obes Relat Metab Disord 2003; 27(1):134-139.
17. Kordy MN el-Gamal FM. A study of pattern of body mass index (BMI) and prevalence of obesity in a Saudi population. Asia Pac Public Health 1995; 8(2):59-65.
18. al-Nuaim AR, al-Rubeaan K, al-Mazrou Y, al-Attas O, al-Daghari N, Khoja T. High prevalence of overweight and obesity in Saudi Arabia. Int Obes Relat Meat Disord 1996; 20:547-552.
19. al-Nuaim AA, Bomgboye EA , al-Rubeaan KA, al-Mazrou Y. Overweight and obesity in Saudi Arabian adult population, role of sociodemographic variables. J community Health 1997; 22:211-223.
20. Pratt DS, Kaplan MM, Evaluation of abnormal liver enzyme results in a symptomatic patients. N Eng J Med 2000; 342:1266-1271.
21. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients .Dig Dis Sci 2000; 45: 129-134.
22. Liangpunsakul S, Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J Clin Gastroenterol. 2003 t; 37(4):340-343.
23. Ballentani S, Saccoccio G, Mastti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132:112-117.
24. Franzese A, Vajro P, Argenziano A, Puzziello A et-al Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population Dig Dis Sci 1997; 42:1428-1432.
25. Garra BS, Insana MF, Shwker TH, Russell MA. Quantitative estimation of liver attenuation and echogenicity: normal state versus diffuse liver disease. Radiology 1987; 162:61-67.
26. Madani KA, AL-Amoudi NS, Kumosani TA. The state of nutrition in Saudi Arabia. Nutr Health 2000; 14:17-31.